James ND - Search Results

1

Recent advances and future directions in the management of metastatic renal cell carcinoma.

Ansari J, Glaholm J, McMenemin R, James ND, Hussain SA. Ansari J, et al. Among authors: james nd. Anticancer Agents Med Chem. 2010 Mar;10(3):225-35. doi: 10.2174/1871520611009030225. Anticancer Agents Med Chem. 2010. PMID: 20184547 Review.

2

Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder.

Hussain SA, Ganesan R, Hiller L, Murray PG, el-Magraby MM, Young L, James ND. Hussain SA, et al. Among authors: james nd. Br J Cancer. 2003 Feb 24;88(4):586-92. doi: 10.1038/sj.bjc.6600765. Br J Cancer. 2003. PMID: 12592374 Free PMC article.

3

Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer.

Hussain SA, Stocken DD, Peake DR, Glaholm JG, Zarkar A, Wallace DM, James ND. Hussain SA, et al. Among authors: james nd. Br J Cancer. 2004 Jun 1;90(11):2106-11. doi: 10.1038/sj.bjc.6601852. Br J Cancer. 2004. PMID: 15150587 Free PMC article. Clinical Trial.

4

A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer.

Hussain SA, Stocken DD, Riley P, Palmer DH, Peake DR, Geh JI, Spooner D, James ND. Hussain SA, et al. Among authors: james nd. Br J Cancer. 2004 Aug 31;91(5):844-9. doi: 10.1038/sj.bjc.6602112. Br J Cancer. 2004. PMID: 15292922 Free PMC article. Clinical Trial.

5

Hepatocellular carcinoma.

Hussain SA, Ferry DR, El-Gazzaz G, Mirza DF, James ND, McMaster P, Kerr DJ. Hussain SA, et al. Among authors: james nd. Ann Oncol. 2001 Feb;12(2):161-72. doi: 10.1023/a:1008370324827. Ann Oncol. 2001. PMID: 11300318 Free article. Review.

6

A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer.

Hussain SA, Moffitt DD, Glaholm JG, Peake D, Wallace DM, James ND. Hussain SA, et al. Among authors: james nd. Ann Oncol. 2001 Jul;12(7):929-35. doi: 10.1023/a:1011133820532. Ann Oncol. 2001. PMID: 11521797 Free article. Clinical Trial.

7

BCL2 expression predicts survival in patients receiving synchronous chemoradiotherapy in advanced transitional cell carcinoma of the bladder.

Hussain SA, Ganesan R, Hiller L, Cooke PW, Murray P, Young LS, James ND. Hussain SA, et al. Among authors: james nd. Oncol Rep. 2003 May-Jun;10(3):571-6. Oncol Rep. 2003. PMID: 12684626

8

A study of split-dose cisplatin-based neo-adjuvant chemotherapy in muscle-invasive bladder cancer.

Hussain SA, Palmer DH, Lloyd B, Collins SI, Barton D, Ansari J, James ND. Hussain SA, et al. Among authors: james nd. Oncol Lett. 2012 Apr 1;3(4):855-859. doi: 10.3892/ol.2012.563. Epub 2012 Jan 12. Oncol Lett. 2012. PMID: 22741006 Free PMC article.

9

Prostate cancer--what should be studied?

James ND, Glaholm J. James ND, et al. Eur J Cancer. 1995 Sep;31A(10):1565-6. doi: 10.1016/0959-8049(95)00390-5. Eur J Cancer. 1995. PMID: 7488401 Review. No abstract available.

10

Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.

Hussain SA, Ganesan R, Reynolds G, Gross L, Stevens A, Pastorek J, Murray PG, Perunovic B, Anwar MS, Billingham L, James ND, Spooner D, Poole CJ, Rea DW, Palmer DH. Hussain SA, et al. Among authors: james nd. Br J Cancer. 2007 Jan 15;96(1):104-9. doi: 10.1038/sj.bjc.6603530. Br J Cancer. 2007. PMID: 17213826 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters